Last updated on February 2020

Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects


Brief description of study

The objective of this study is to evaluate the safety profile of Adalimumab for Hidradenitis Suppurativa (HS) participants in normal medical practice.

Clinical Study Identifier: NCT03001115

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.